LONDON, July 24 GlaxoSmithKline has
appointed international law firm Ropes & Gray to carry out an
independent review into alleged corruption by senior executives
in its Chinese business, a spokesman for the drugmaker said.
Andrew Witty, chief executive of Britain's biggest
pharmaceuticals group, said earlier on Wednesday that he was
commissioning the independent review "to investigate what has
Ropes & Gray has offices in the United States, London and
Asia, including Shanghai and Hong Kong, according to its
Chinese police have detained four Chinese executives from
GSK and accused the company of funnelling up to 3 billion yuan
($489 million) to travel agencies to facilitate bribes to
doctors and officials to boost sales and drug prices.
GSK, which reported second-quarter results on Wednesday,
said the "shameful" allegations would inevitably have some
impact on its business.